Notification of Interim Results

RNS Number : 1506F

Futura Medical PLC

21 May 2013

 



For immediate release

21 May 2013

 

 

Futura Medical PLC

("Futura" or the "Company")

Notification of Interim Results

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, will announce its interim results for the six months ended 30 June 2013 on Thursday 12 September 2013.

A briefing for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan, 107 Cheapside, London, EC2V 6DN.

For more information, or to register attendance, please contact Buchanan on 020 7466 5000.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles www.buchanan.uk.com	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

NOREASSEASDDEFF